<Record>
<Term>Monoclonal Antibody HuMV833</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<ParentTerm>Monoclonal Antibody</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Biological Agent/Monoclonal Antibody/Monoclonal Antibody HuMV833,/NCIThesaurus/Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Antineoplastic Agent/Angiogenesis Inhibitor/Angiogenesis Activator Inhibitor/Monoclonal Antibody HuMV833</ClassificationPath>
<BroaderTerm>Monoclonal Antibody HuMV833</BroaderTerm>
<BroaderTerm>Angiogenesis Activator Inhibitor</BroaderTerm>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antineoplastic Agent</BroaderTerm>
<BroaderTerm>Biological Agent</BroaderTerm>
<BroaderTerm>Angiogenesis Inhibitor</BroaderTerm>
<BroaderTerm>NCIThesaurus</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Monoclonal Antibody</BroaderTerm>
<BroaderTerm>Monoclonal Antibody HuMV833,</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>HuMV833</Synonym>
<Synonym>MoAb HuMV833</Synonym>
<Synonym>Monoclonal Antibody HuMV833</Synonym>
<Description>A humanized monoclonal antibody directed against vascular endothelial growth factor (VEGF), a pro-angiogenic cytokine.  HuMV833 has been shown to decrease the permeability of blood vessels that supply tumors, an effect which may lead to slowed tumor growth. (NCI04)</Description>
<Source>NCI Thesaurus</Source>
</Record>
